GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

firsekibart   Click here for help

GtoPdb Ligand ID: 14399

Synonyms: Jin Beixin® (China)
Approved drug
firsekibart is an approved drug
Compound class: Antibody
Comment: Firsekibart (previously genakumab) is an IgG4λ monoclonal antibody that targets interleukin-1β (IL-1β). It was developed for anti-inflammatory potential. Based on peptide sequence matches for the heavy and light variable regions of firsekibart, this appears to be antibody 048Ab-4 (H2L6) in patent CN106928354A [2].
Classification Click here for help
Compound class Antibody
Approved drug? Yes. China NMPA (2025)
International Nonproprietary Names Click here for help
INN number INN
13353 firsekibart
Synonyms Click here for help
Jin Beixin® (China)
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1746
Other databases
GtoPdb PubChem SID 523352191
Search PubMed clinical trials firsekibart
Search PubMed titles firsekibart
Search PubMed titles/abstracts firsekibart